Evidence map›Paper›PMID 21330457›Full record

Trial reportAmerican journal of respiratory and critical care medicine2011

SOX5 is a candidate gene for chronic obstructive pulmonary disease susceptibility and is necessary for lung development.

Craig P Hersh, Edwin K Silverman, Jody Gascon, Soumyaroop Bhattacharya, Barbara J Klanderman, Augusto A Litonjua, Véronique Lefebvre, David Sparrow, John J Reilly, Wayne H Anderson and 2 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Discovery ofDiagnostics (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Role of SOX Transcription Factors in Ageing and Age-Related Diseases.International journal of molecular sciences · 2023
    Review
  10. Review
  11. LncRNA UCC promotes epithelial-mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  12. Review
  13. Review
  14. Pharmacogenomics of chronic obstructive pulmonary disease.Expert review of respiratory medicine · 2019
    Review
  15. The etiologic origins for chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2019
    Review
  16. Article
  17. Human airway branch variation and chronic obstructive pulmonary disease.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 2 countries.

Craig P HershChanning Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA. craig.hersh@channing.harvard.edu
Edwin K Silverman
Jody Gascon
Soumyaroop Bhattacharya
Barbara J Klanderman
Augusto A Litonjua
Véronique Lefebvre
David Sparrow
John J Reilly
Wayne H Anderson
David A Lomas
Thomas J Mariani
Brigham and Women's Hospital · USUniversity of Rochester · USBoston University · USCleveland Clinic Lerner College of Medicine · USCOPD Foundation · USHarvard University Press · USResearch Triangle Park Foundation · USUniversity of Pittsburgh · US

Funding

Statistical GeneticsP01HL083069 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 2007 to 2011
$12.2M
Fine Mapping of COPD Susceptibility GenesR01HL075478 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2004 to 2012
$6.4M
Functional Genomic Biomarkers in COPDR01HL072303 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI REILLY, JOHN J · 2002 to 2005
$2.2M
LONG-TERM OXYGEN TREATMENT TRIAL (LOTT) PHARMACOGENOMICS ANCILLARY STUDYR01HL094635 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HERSH, CRAIG P · 2009 to 2014
$2.2M
Functional Genomics of AlveogenesisR01HL071885 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MARIANI, THOMAS J · 2003 to 2006
$1.4M
CLINICAL COORDINATING CENTER FOR LVRS-N01HR76119-268076119-268076119N01HR076119 · HR · JOHNS HOPKINS UNIVERSITY · PI PIANTADOSI, STEVEN · 1997 to 2006
$871k
Fine Mapping of a COPD Locus on Chromosome 19qK08HL080242 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI HERSH, CRAIG P · 2005 to 2009
$668k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076118 · HR · UNIVERSITY OF WASHINGTON · PI ALBERT, RICHARD K · 1997 to 2000
$225k
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTERN01HR076113 · HR · UNIVERSITY OF PENNSYLVANIA · PI KAISER, LARRY · 1997 to 2000
$208k
CLNICAL CENTER FOR LVRSN01HR076104 · HR · CEDARS-SINAI MEDICAL CENTER · PI MCKENNA, RICHARD · 1997 to 2000
$153k
CLNICAL CENTER FOR THE LVRSN01HR076102 · HR · BRIGHAM AND WOMEN'S HOSPITAL · PI REILLY, JOHN J · 1997 to 2000
$150k
CLINICAL CENTER FOR LVRSN01HR076114 · HR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KEENAN, ROBERT J · 1997 to 2000
$147k
Medical Research Council G0000934Medical Research Council G0901786NHLBI NIH HHS HL071885NHLBI NIH HHS HL075478NHLBI NIH HHS HL080242NHLBI NIH HHS HL094635NHLBI NIH HHS HL72303NHLBI NIH HHS N01HR76101NHLBI NIH HHS N01HR76102NHLBI NIH HHS N01HR76103NHLBI NIH HHS N01HR76104NHLBI NIH HHS N01HR76105NHLBI NIH HHS N01HR76106NHLBI NIH HHS N01HR76107NHLBI NIH HHS N01HR76108NHLBI NIH HHS N01HR76109NHLBI NIH HHS N01HR76110NHLBI NIH HHS N01HR76111NHLBI NIH HHS N01HR76112NHLBI NIH HHS N01HR76113NHLBI NIH HHS N01HR76114NHLBI NIH HHS N01HR76115NHLBI NIH HHS N01HR76116NHLBI NIH HHS N01HR76118NHLBI NIH HHS N01HR76119NHLBI NIH HHS P01 HL083069NHLBI NIH HHS R01 HL094635Wellcome Trust 068545/Z/02
6 · The paper itself

Abstract

rationaleChromosome 12p has been linked to chronic obstructive pulmonary disease (COPD) in the Boston Early-Onset COPD Study (BEOCOPD), but a susceptibility gene in that region has not been identified.

objectivesWe used high-density single-nucleotide polymorphism (SNP) mapping to implicate a COPD susceptibility gene and an animal model to determine the potential role of SOX5 in lung development and COPD.

methodsOn chromosome 12p, we genotyped 1,387 SNPs in 386 COPD cases from the National Emphysema Treatment Trial and 424 control smokers from the Normative Aging Study. SNPs with significant associations were then tested in the BEOCOPD study and the International COPD Genetics Network. Based on the human results, we assessed histology and gene expression in the lungs of Sox5(-/-) mice. MEASUREMENTS AND MAIN

resultsIn the case-control analysis, 27 SNPs were significant at P ≤ 0.01. The most significant SNP in the BEOCOPD replication was rs11046966 (National Emphysema Treatment Trial-Normative Aging Study P = 6.0 × 10(-4), BEOCOPD P = 1.5 × 10(-5), combined P = 1.7 × 10(-7)), located 3' to the gene SOX5. Association with rs11046966 was not replicated in the International COPD Genetics Network. Sox5(-/-) mice showed abnormal lung development, with a delay in maturation before the saccular stage, as early as E16.5. Lung pathology in Sox5(-/-) lungs was associated with a decrease in fibronectin expression, an extracellular matrix component critical for branching morphogenesis.

conclusionsGenetic variation in the transcription factor SOX5 is associated with COPD susceptibility. A mouse model suggests that the effect may be due, in part, to its effects on lung development and/or repair processes.

Indexed as

AgedAnimalsCase-Control StudiesDisease Models, AnimalFemaleGenetic Predisposition to DiseaseHumansMaleMiceMiddle AgedPolymorphism, Single NucleotidePulmonary Disease, Chronic ObstructiveSOXD Transcription FactorsSOX5 protein, humanSox5 protein, mouseSOXD Transcription Factors

Identifiers

PMID21330457
PMCPMC3137139
OpenAlexW2091842562

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.